, India

India’s hospital industry enjoys high investment demand

Demand for health services is rising in Tier 2 and Tier 3 locations.

India’s hospital industry is witnessing huge demand from both global and domestic investors, and there is tremendous interest in tertiary care hosptials and specialty hospitals in particular, according to a report from NITI Aayog.

The government’s plans to ramp up budgetary allocation for public health spending to 2.5% of the country’s GDP by 2025 will benefit the hospital sector as well.

Currently, there is a gap between the number of beds available and the number of beds required. India’s hospital bed density is less than half the global average of 3 hospital beds per 1,000 population, implying that an estimated 2.2 million beds will be required over the next 15 years.

Apart from metropolitan cities, demand for health services is rising in Tier 2 and Tier 3 locations across the country. The per-capita income in these locations has risen rapidly over the past few  years, the report noted.

“Further, inputs such as land and labour are available at a lower cost in these cities. An added advantage is that these locations can also cater to the population in nearby villages and towns,” NITI Aayog added.

There are nearly 600 investment opportunities worth $32b (INR2.3 lakh crore) in the hospital and medical infrastructure sub-sector on Indian Investment Grid (IIG), a platform maintained by Invest India for showcasing investment opportunities by sector.

Meanwhile, stressed  assets in the hospital industry could be given preference as brownfield projects to healthcare investors by enabling them to diagnose the challenges. “This will ensure a significant reduction in the burden of sick industries in the healthcare sector as well as  utilization/upgradation of existing resources by reducing the expenditure,” the report added.

The hospital industry in India accounts for 80% of the country’s healthcare market. It was valued at $61.79b in FY17 and is expected to reach $132b by 2023, growing at a compound annual growth rate (CAGR) of 16-17%.

NITI Aayog said that the long-term outlook for the hospital sector is stable, with annual revenues likely to rise over the next few years on account of rising domestic demand for healthcare as well as medical  tourism.

Since you're here...

...there are many ways you can work with us to advertise your company and connect to your customers. Our team can help you dight and create an advertising campaign, in print and digital, on this website and in print magazine.

We can also organize a real life or digital event for you and find thought leader speakers as well as industry leaders, who could be your potential partners, to join the event. We also run some awards programmes which give you an opportunity to be recognized for your achievements during the year and you can join this as a participant or a sponsor.

Let us help you drive your business forward with a good partnership!

Get Health Care Asia Magazine in your inbox
It was recognised for its cutting-edge medical device packaging design, Dispenser Integrated System Kit (DISK).
There has been an expanding research base across India, China, and Japan.
It combines third-party assured data verification with blockchain technology.
Consultation is available for only $0.014 (INR1).
The number of hospitals operating on hip fracture that have access to a fracture liaison service has been steadily rising from 2013 to 2020.
GMT Manila’s award-winning initiative, in collaboration with Endec Inc. and Scilore LLC, is a rapidly deployable turnkey solution for RT-PCR Testing that made it more available across the Philippines. 
As The National Cardiovascular Referral Center in Indonesia, NCCHK has been acknowledged by Asia's Healthcare Industry.
Currently, North America dominates the market across the globe.
More medical devices are being bought for home use.
It has also introduced a new hotline service.
The firm was recognised for its multiple initiatives in braving the COVID-19 crisis.
It took home the Training Initiative of the Year trophy for its non-invasive therapy treatment for benign prostatic hyperplasia (BPH).
The country’s SII makes up about half of Covax supply.
It owns 39 hospitals and eight clinics across England, Wales, and Scotland.
The company plans to set up over 100 in-school clinics.